Global migration and the changing distribution of sickle haemoglobin: A quantitative study of temporal trends between 1960 and 2000

The Lancet Global Health

Volumn 2, Issue 2, 2014, Pages

  Piel, Frédéric B ^a,b   Tatem, Andrew J ^c,d   Huang, Zhuojie ^e   Gupta, Sunetra ^a   Williams, Thomas N ^b,f,g   Weatherall, David J ^h  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b Global Network for Sickle Cell Disease   (Canada)

^c UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

^d NATIONAL INSTITUTES OF HEALTH   (United States)

^e PENNSYLVANIA STATE UNIVERSITY   (United States)

^f KENYA MEDICAL RESEARCH INSTITUTE   (Kenya)

^g ST MARY S HOSPITAL   (United Kingdom)

^h UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

HEMOGLOBIN S;

BAYES THEOREM; EVALUATION STUDY; FACTUAL DATABASE; GENE FREQUENCY; GENETICS; HEALTH; HEMOGLOBINURIA; HUMAN; MIGRANT; POPULATION GENETICS; STATISTICS AND NUMERICAL DATA;

BAYES THEOREM; DATABASES, FACTUAL; EMIGRANTS AND IMMIGRANTS; EVALUATION STUDIES AS TOPIC; GENE FREQUENCY; GENETICS, POPULATION; GLOBAL HEALTH; HEMOGLOBIN, SICKLE; HEMOGLOBINURIA; HUMANS;

EID: 84892951517     PISSN: None     EISSN: 2214109X     Source Type: Journal    
DOI: 10.1016/S2214-109X(13)70150-5     Document Type: Article

References (63)

1. Özden Ç, Parsons CR, Schiff M, Walmsley TL Where on earth is everybody? The evolution of global bilateral migration 1960-2000 (accessed Jan 1, 2014). http://www-wds.worldbank.org/servlet/WDSContentServer/WDSP/IB/2011/06/28/000158349_20110628100223/Rendered/PDF/WPS5709.pdf.
2. Davis KF, D'Odorico P, Laio F, Ridolfi L Global spatio-temporal patterns in human migration: a complex network perspective. PloS One 2013, 8:e53723.
3. The world health report 2007-a safer future: global public health security in the 21st century 2007, WHO, World Health Organization, Geneva.
4. Gushulak B, Weekers J, Macpherson D Migrants and emerging public health issues in a globalized world: threats, risks and challenges, an evidence-based framework. Emerg Health Threats J 2009, 2:e10.
5. Zimmerman C, Kiss L, Hossain M Migration and health: a framework for 21st century policy-making. Plos Med 2011, 8:e1001034.
6. Rechel B, Mladovsky P, Ingleby D, Mackenbach JP, McKee M Migration and health in an increasingly diverse Europe. Lancet 2013, 381:1235-1245.
7. Bedford T, Cobey S, Beerli P, Pascual M Global migration dynamics underlie evolution and persistence of human influenza A (H3N2). PLoS Pathog 2010, 6:e1000918.
8. Stoddard ST, Morrison AC, Vazquez-Prokopec GM, et al. The role of human movement in the transmission of vector-borne pathogens. PLoS Negl Trop Dis 2009, 3:e481.
9. Tatem AJ, Huang Z, Das A, Qi Q, Roth J, Qiu Y Air travel and vector-borne disease movement. Parasitology 2012, 139:1816-1830.
10. Angastiniotis M, Vives-Corrons JL, Soteriades E, Eleftheriou A The impact of migrations on the health services for rare diseases in Europe: the example of haemoglobin disorders. Sci World J 2013, 2013:727905.
11. Modell B, Bulyzhenkov V Distribution and control of some genetic disorders. World Health Stat Q 1988, 41:209-218.
12. Keinan A, Clark AG Recent explosive human population growth has resulted in an excess of rare genetic variants. Science 2012, 336:740-743.
13. Giordano PC Prospective and retrospective primary prevention of hemoglobinopathies in multiethnic societies. Clin Biochem 2009, 42:1757-1766.
14. Vichinsky EP Changing patterns of thalassemia worldwide. Ann N Y Acad Sci 2005, 1054:18-24.
15. Fifty-ninth World Health Assembly: resolutions and decisions, annexes (WHA59/2006/REC/1) 2006, WHO, World Health Organization, Geneva.
16. Serjeant GR Geographic hetereogeneity of sickle cell disease. Disorders of hemoglobin 2001, 895-905. Cambridge University Press, Cambridge. 1st edn. M.H. Steinberg, B.G. Forget, D.R. Higgs, R.L. Nagel (Eds.).
17. Rees DC, Williams TN, Gladwin MT Sickle-cell disease. Lancet 2010, 376:2018-2031.
18. Allison AC The distribution of the sickle-cell trait in East Africa and elsewhere, and its apparent relationship to the incidence of subtertian malaria. Trans R Soc Trop Med Hyg 1954, 48:312-318.
19. Allison AC Protection afforded by sickle-cell trait against subtertian malareal infection. BMJ 1954, 1:290-294.
20. Livingstone FB Frequencies of hemoglobin variants: thalassemia, the glucose-6-phosphate dehydrogenase deficiency, G6PD variants, and ovalocytosis in human populations 1985, Oxford University Press, New York.
21. Piel FB, Patil AP, Howes RE, et al. Global distribution of the sickle cell gene and geographical confirmation of the malaria hypothesis. Nat Commun 2010, 1:104.
22. Mednick LW, Orans M The sickle-cell gene: migration versus selection. Am Anthropologist 1956, 58:293-295.
23. Pante-de-Sousa G, Mousinho-Ribeiro RD, dos Santos EJM, Zago MA, Guerreiro JF Origin of the hemoglobin S gene in a northern Brazilian population: the combined effects of slave trade and internal migrations. Genet Mol Biol 1998, 21:427-430.
24. Hassell KL Population estimates of sickle cell disease in the US. Am J Prev Med 2010, 38(4 suppl):S512-S521.
25. Lemos Cardoso G, Farias Guerreiro J African gene flow to north Brazil as revealed by HBB*S gene haplotype analysis. Am J Hum Biol 2006, 18:93-98.
26. King L, Fraser R, Forbes M, Grindley M, Ali S, Reid M Newborn sickle cell disease screening: the Jamaican experience (1995-2006). J Med Screen 2007, 14:117-122.
27. Weatherall DJ The inherited diseases of hemoglobin are an emerging global health burden. Blood 2010, 115:4331-4336.
28. Weatherall DJ, Clegg JB Inherited haemoglobin disorders: an increasing global health problem. Bull World Health Organ 2001, 79:704-712.
29. Weatherall DJ The challenge of haemoglobinopathies in resource-poor countries. Br J Haematol 2011, 154:736-744.
30. Streetly A, Clarke M, Downing M, et al. Implementation of the newborn screening programme for sickle cell disease in England: results for 2003-2005. J Med Screen 2008, 15:9-13.
31. Parsons CR, Skeldon R, Walmsley TL, Winters LA Quantifying international migration: a database of bilateral migrant stocks 2007, World Bank, Washington, DC.
32. Piel FB, Patil AP, Howes RE, et al. Global epidemiology of sickle haemoglobin in neonates: a contemporary geostatistical model-based map and population estimates. Lancet 2013, 381:142-151.
33. Hardy GH Mendelian proportions in a mixed population. 1908. Science 2003, 76:79-80.
34. Weinberg W On the demonstration of heredity in man. Jahresh Wuertt Verh Vaterl Naturkd 1908, 64:369-382. (in German).
35. R: A language and environment for statistical computing 2012, R Core Team, R Foundation for Statistical Computing, Vienna.
36. Cataldo F Immigration and changes in the epidemiology of hemoglobin disorders in Italy: an emerging public health burden. Ital J Pediatr 2012, 38:32.
37. Roberts I, de Montalembert M Sickle cell disease as a paradigm of immigration hematology: new challenges for hematologists in Europe. Haematologica 2007, 92:865-871.
38. Dickerhoff R, Genzel-Boroviczeny O, Kohne E Haemoglobinopathies and newborn haemoglobinopathy screening in Germany. J Clin Pathol 2009, 62:34.
39. Wonkam A, Ponde C, Nicholson N, Fieggen K, Ramessar R, Davidson A The burden of sickle cell disease in Cape Town. S Afr Med J 2012, 102:752-754.
40. Theodorsson E, Birgens H, Hagve TA Haemoglobinopathies and glucose-6-phosphate dehydrogenase deficiency in a Scandinavian perspective. Scand J Lab Clin Invest 2007, 67:3-10.
41. Teoh Y, Greenway A, Savoia H, Monagle P, Roy J, Barnes C Hospitalisations for sickle-cell disease in an Australian paediatric population. J Paediatr Child Health 2013, 49:68-71.
42. Gergen PJ, Macri CJ, Murrillo S The need for sickle cell screening among pediatric latino immigrants. Arch Pediatr Adolesc Med 2002, 156:729.
43. Grosse SD, Olney RS, Baily MA The cost effectiveness of universal versus selective newborn screening for sickle cell disease in the US and the UK: a critique. Appl Health Econ Health Pol 2005, 4:239-247.
44. Patch C Newborn screening policy in the United Kingdom & the United States: two different communities of practice. MCN Am J Matern Child Nurse 2006, 31:164-168.
45. Jans SM, van El CG, Houwaart ES, et al. A case study of haemoglobinopathy screening in the Netherlands: witnessing the past, lessons for the future. Ethn Health 2012, 17:217-239.
46. Bardakdjian-Michau J, Bahuau M, Hurtrel D, et al. Neonatal screening for sickle cell disease in France. J Clin Pathol 2009, 62:31-33.
47. Voskaridou E, Ladis V, Kattamis A, et al. A national registry of haemoglobinopathies in Greece: deducted demographics, trends in mortality and affected births. Ann Hematol 2012, 91:1451-1458.
48. Kyrri AR, Felekis X, Kalogerou E, et al. Hemoglobin variants in Cyprus. Hemoglobin 2009, 33:81-94.
49. Colombatti R, Montanaro M, Guasti F, et al. Comprehensive care for sickle cell disease immigrant patients: a reproducible model achieving high adherence to minimum standards of care. Pediatr Blood Cancer 2012, 59:1275-1279.
50. Dong A, Rivella S, Breda L Gene therapy for hemoglobinopathies: progress and challenges. Transl Res 2013, 161:293-306.
51. Kauf TL, Coates TD, Huazhi L, Mody-Patel N, Hartzema AG The cost of health care for children and adults with sickle cell disease. Am J Hematol 2009, 84:323-327.
52. Alswaidi FM, O'Brien SJ Premarital screening programmes for haemoglobinopathies, HIV and hepatitis viruses: review and factors affecting their success. J Med Screen 2009, 16:22-28.
53. Cao A, Galanello R Effect of consanguinity on screening for thalassemia. New Engl J Med 2007, 9:372-377.
54. AlHamdan NA, AlMazrou YY, AlSwaidi FM, Choudhry AJ Premarital screening for thalassemia and sickle cell disease in Saudi Arabia. Genet Med 2007, 9:372-377.
55. Odame I, Kulkarni R, Ohene-Frempong K Concerted global effort to combat sickle cell disease: the first global congress on sickle cell disease in Accra, Ghana. Am J Prev Med 2011, 41(6 Suppl 4):S417-S421.
56. Hardison RC, Chui DH, Giardine B, et al. A relational database of human hemoglobin variants and thalassemia mutations at the globin gene server. Human Mutation 2002, 19:225-233.
57. McBride KL, Snow K, Kubik KS, et al. Hb Dartmouth [alpha66(E15)Leu-→Pro (alpha2) (CTG→CCG)]: a novel alpha2-globin gene mutation associated with severe neonatal anemia when inherited in trans with Southeast Asian alpha-thalassemia-1. Hemoglobin 2001, 25:375-382.
58. Raymer J, Smith PWF Modelling migration flows. J R Stat Soc 2010, 173:703-705.
59. Abel GJ Estimation of international migration flow tables in Europe. J R Stat Soc 2010, 173:797-825.
60. Bijak J, Wiśniowski A Bayesian forecasting of immigration to selected European countries by using expert knowledge. J R Stat Soc 2010, 173:775-796.
61. Panepinto JA, Magid D, Rewers MJ, Lane PA Universal versus targeted screening of infants for sickle cell disease: a cost-effectiveness analysis. J Pediatr 2000, 136:201-208.
62. Prior JF, Bittles AH, Erber WN A community profile of alpha thalassaemia in Western Australia. Community Genet 2004, 7:211-215.
63. Rezaee AR, Banoei MM, Khalili E, Houshmand M Beta-thalassemia in Iran: new insight into the role of genetic admixture and migration. SciWorld Jnal 2012, 2012:635183.